Germany-based Sanner will build a new production facility and headquarters in Bensheim, Germany. The aim is to increase the company’s capacity for catering to the customers’ diverse requirements in pharmaceuticals, medical devices, and diagnostics packaging solutions.

The new facility will be capable of manufacturing desiccant or effervescent packaging for medical technology, diagnostics, mechatronic pharma drug delivery systems and drug handling.

The ground-breaking ceremony for the facility took place in January 2023. The company will relocate its production completely to the new facility, following its opening in September 2024.

The facility will be located in the Stubenwald II industrial park in Bensheim.

The new state-of-the-art facility will cover an area of approximately 30,000m² in the Stubenwald II industrial park, which will more than double the existing production capacity of Sanner in Germany.

Sanner Technikum, a new technology and innovation centre, will be developed in a 300m² area within the facility to develop customised solutions and prototypes.

The facility will be designed with a flexible moulding and assembly production floor, which can adapt to customers’ needs in both the packaging and device contract development manufacturing and organisation (CDMO) areas, as well as electrostatic discharge (ESD) floors for electronic medical device components.

The facility will be installed with highly automated equipment and an automated central material supply to feed all machines. It will have separate areas for desiccant and injection moulding.

A fully automated stock management system will double the existing capacity of the warehouse. The facility will feature classes 7 and 8 clean rooms, as well as additional capacity to address the current and anticipated future demand.